Effects of therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate on endocrine function

PURPOSE: Peptide receptor radionuclide therapy (PRRT) with radiolabelled somatostatin analogues is a novel therapy for patients with somatostatin receptor-positive tumours. We determined the effects of PRRT with [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-octreotate) on glucose homeostasis and the p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Teunissen, Jaap J. M., Krenning, Eric P., de Jong, Frank H., de Rijke, Yolanda B., Feelders, Richard A., van Aken, Maarten O., de Herder, Wouter W., Kwekkeboom, Dik J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer-Verlag 2009
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764054/
https://ncbi.nlm.nih.gov/pubmed/19471926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-009-1151-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi